What do systematic reviews say?

Bevacizumab plus chemotherapy vs chemotherapy alone

Bevacizumab plus chemotherapy may leads to higher specific adverse events: serious haemorrhage compared with chemotherapy (low certainty).

• Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer 2021 · Cochrane Headline outcomes only
  RR 5 [1.11, 22.56]
  1 study · 440 participants
  Low